Company Announcements

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 ______________________________________________________________________________
|1 |Details of the person discharging managerial responsibilities / person     |
|  |closely associated                                                         |
|__|___________________________________________________________________________|
|a)|Name                                    |Roger Yates                       |
|__|________________________________________|__________________________________|
|2 |Reason for the notification                                                |
|__|___________________________________________________________________________|
|a)|Position/status                         |Non-executive Director            |
|__|________________________________________|__________________________________|
|b)|Initial notification /Amendment         |Initial notification              |
|__|________________________________________|__________________________________|
|3 |Details of the issuer, emission allowance market participant, auction      |
|  |platform, auctioneer or auction monitor                                    |
|__|___________________________________________________________________________|
|a)|Name                                    |The Biotech Growth Trust PLC      |
|__|________________________________________|__________________________________|
|b)|LEI                                     |549300Z41EP32MI2DN29              |
|__|________________________________________|__________________________________|
|  |Details of the transaction(s): section to be repeated for (i) each type of |
|4 |instrument; (ii) each type of transaction; (iii) each date; and (iv) each  |
|  |place where transactions have been conducted                               |
|__|___________________________________________________________________________|
|  |Description of the financial instrument,|Ordinary 25p shares               |
|a)|type of instrument                      |                                  |
|  |                                        |GB0000385517                      |
|  |Identification code                     |                                  |
|__|________________________________________|__________________________________|
|b)|Nature of the transaction               |Acquisition of Shares             |
|__|________________________________________|__________________________________|
|  |                                        | ________________________________ |
|  |                                        ||Price(s)              |Volume(s)||
|c)|Price(s) and volume(s)                  ||______________________|_________||
|  |                                        ||969.00 pence per share|5,000    ||
|  |                                        ||______________________|_________||
|__|________________________________________|__________________________________|
|  |Aggregated information                  |                                  |
|  |                                        |5,000 ordinary 25p shares         |
|d)|- Aggregated volume                     |                                  |
|  |                                        |969.00 pence per share            |
|  |- Price                                 |                                  |
|__|________________________________________|__________________________________|
|e)|Date of the transaction                 |14 March 2024                     |
|__|________________________________________|__________________________________|
|f)|Place of the transaction                |London Stock Exchange (XLON)      |
|__|________________________________________|__________________________________|

 

Name of authorised official of issuer responsible for making notification:

 

Katherine Manson, for and on behalf of Frostrow Capital LLP

Company Secretary to THE BIOTECH GROWTH TRUST PLC